441 related articles for article (PubMed ID: 28427243)
1. USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4.
Li Y; Yang Y; Li J; Liu H; Chen F; Li B; Cui B; Liu Y
Oncotarget; 2017 May; 8(20):32683-32695. PubMed ID: 28427243
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-302c represses epithelial-mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer.
Ma W; Liu B; Li J; Jiang J; Zhou R; Huang L; Li X; He X; Zhou Q
Biomed Pharmacother; 2018 Sep; 105():670-676. PubMed ID: 29906744
[TBL] [Abstract][Full Text] [Related]
4. p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer.
Shi L; Jackstadt R; Siemens H; Li H; Kirchner T; Hermeking H
Cancer Res; 2014 Jan; 74(2):532-42. PubMed ID: 24285725
[TBL] [Abstract][Full Text] [Related]
5. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
6. AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer.
Jackstadt R; Röh S; Neumann J; Jung P; Hoffmann R; Horst D; Berens C; Bornkamm GW; Kirchner T; Menssen A; Hermeking H
J Exp Med; 2013 Jul; 210(7):1331-50. PubMed ID: 23752226
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-Specific Peptidase 22 Contributes to Colorectal Cancer Stemness and Chemoresistance via Wnt/β-Catenin Pathway.
Jiang S; Song C; Gu X; Wang M; Miao D; Lv J; Liu Y
Cell Physiol Biochem; 2018; 46(4):1412-1422. PubMed ID: 29689565
[TBL] [Abstract][Full Text] [Related]
8. Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma.
Mesci A; Taeb S; Huang X; Jairath R; Sivaloganathan D; Liu SK
World J Gastroenterol; 2014 Dec; 20(46):17376-87. PubMed ID: 25516649
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic suppression of E-cadherin expression by Snail2 during the metastasis of colorectal cancer.
Hu Y; Dai M; Zheng Y; Wu J; Yu B; Zhang H; Kong W; Wu H; Yu X
Clin Epigenetics; 2018 Dec; 10(1):154. PubMed ID: 30541610
[TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer.
Liu YL; Yang YM; Xu H; Dong XS
J Surg Oncol; 2011 Mar; 103(3):283-9. PubMed ID: 21337558
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
13. Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.
Wu Y; Peng Y; Wu M; Zhang W; Zhang M; Xie R; Zhang P; Bai Y; Zhao J; Li A; Nan Q; Chen Y; Ren Y; Liu S; Wang J
Oncotarget; 2016 Aug; 7(32):51150-51162. PubMed ID: 27223064
[TBL] [Abstract][Full Text] [Related]
14. Karyopherin β1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expression.
Zhang Y; Li KF
Biomed Pharmacother; 2019 Dec; 120():109127. PubMed ID: 31629952
[TBL] [Abstract][Full Text] [Related]
15. AP4 activates cell migration and EMT mediated by p53 in MDA-MB-231 breast carcinoma cells.
Chen S; Chiu SK
Mol Cell Biochem; 2015 Sep; 407(1-2):57-68. PubMed ID: 26037074
[TBL] [Abstract][Full Text] [Related]
16. DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC.
Liu YP; Zhu HF; Liu DL; Hu ZY; Li SN; Kan HP; Wang XY; Li ZG
Oncotarget; 2016 Nov; 7(47):77306-77318. PubMed ID: 27764793
[TBL] [Abstract][Full Text] [Related]
17. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
[TBL] [Abstract][Full Text] [Related]
18. OCT4 regulates epithelial-mesenchymal transition and its knockdown inhibits colorectal cancer cell migration and invasion.
Dai X; Ge J; Wang X; Qian X; Zhang C; Li X
Oncol Rep; 2013 Jan; 29(1):155-60. PubMed ID: 23076549
[TBL] [Abstract][Full Text] [Related]
19. USP22 promotes tumor progression and induces epithelial-mesenchymal transition in lung adenocarcinoma.
Hu J; Yang D; Zhang H; Liu W; Zhao Y; Lu H; Meng Q; Pang H; Chen X; Liu Y; Cai L
Lung Cancer; 2015 Jun; 88(3):239-45. PubMed ID: 25907317
[TBL] [Abstract][Full Text] [Related]
20. Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer.
Fan LC; Teng HW; Shiau CW; Tai WT; Hung MH; Yang SH; Jiang JK; Chen KF
Oncotarget; 2016 Sep; 7(39):64136-64147. PubMed ID: 27580057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
